Dartmouth/Veterans Affairs researchers have tested whether a primer, which the researchers also wrote, helped people better understand information about health risks and interventions meant to reduce those risks.
The current battle between the makers of anti-wrinkle products – widely compared with the Coke and Pepsi struggle for superiority – is receiving an injection of scientific understanding with the release of a new study from the University of Michigan Health System.
A new study from Saint Louis University researchers shows that young transplant patients who lose their federally provided insurance coverage are more likely to stop taking necessary anti-rejection drugs, which can increase the risk of losing the transplanted organs.
A new study led by researchers at the McGill University Health Centre (MUHC) has identified four genes that increase the risk of developing type 2 diabetes.
The University of Texas at San Antonio and the University of Texas Health Science Center at San Antonio have had success in early trials to discover a vaccine that will prevent chlamydia — the most common bacteria-related sexually transmitted disease in the United States.
C-Reactive Protein, widely regarded as a risk factor for hypertension and other forms of cardiovascular disease, plays a direct role in the onset of hypertension, researchers at UT Southwestern Medical Center have found.
Obesity is generally discussed in terms of caloric intake (how much a person eats) and energy output (how much a person exercises). However, according to a University of Missouri-Columbia scientist, environmental chemicals found in everyday plastics and pesticides also may influence obesity.
On Feb. 18, Nature Genetics will publish the largest-ever study on the genetics of autism. The research is the fruit of an international autism genetics consortium, called the Autism Genome Project.
Three years ago Mark Kay, MD, PhD, published the first results showing that a biological phenomenon called RNA interference could be an effective gene therapy technique. Since then he has used RNAi gene therapy to effectively shut down the viruses that cause hepatitis and HIV in mice.
When cells become cancerous, they also become 100 times more likely to genetically mutate than regular cells, researchers have found. The findings may explain why cells in a tumor have so many genetic mutations, but could also be bad news for cancer treatments that target a particular gene controlling cancer malignancy.